Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Stressor-Focused Therapy for Emotional Processing in Adjustment Disorder (STEP)

14. listopadu 2026 aktualizováno: Rahel Bachem

STEP - Stressor-focused Therapy for Emotional Processing in ICD-11 Adjustment Disorder: A Randomised Waitlist-Controlled Trial

This randomized controlled trial evaluates the efficacy of STEP, a brief 12-session psychotherapy for adults with ICD-11 Adjustment Disorder (AjD). STEP is a manualized, CBT-based, event-focused intervention designed to reduce Adjustment Disorder symptoms and support adaptive emotional processing and coping. Participants in the waitlist control group will receive STEP after the 12-week waiting period. Outcomes will be assessed at baseline, post-treatment, and at a 3-month follow-up. The primary outcome is Adjustment Disorder symptom severity. Secondary outcomes include perceived stress, depression, anxiety, well-being, and experiential avoidance.

Přehled studie

Postavení

Zatím nenabíráme

Intervence / Léčba

Detailní popis

Adjustment disorder (AjD) is characterised in ICD-11 by two core symptom clusters: preoccupation with the stressor and failure to adapt. Although adjustment disorder is frequently diagnosed in clinical practice, evidence for disorder-specific psychological treatments based on the ICD-11 conceptualisation remains limited.

STEP (Stressor-focused Therapy for Emotional Processing) was developed to address these core symptoms through a structured, event-focused cognitive-behavioural approach. The treatment is based on the conceptualisation of adjustment disorder as a stress-response syndrome, in which persistent preoccupation with a stressful life event and avoidance of associated memories, thoughts, and emotions may contribute to symptom maintenance.

Drawing on established cognitive-behavioural and trauma-focused treatment principles, STEP integrates psychoeducation, individual case formulation, emotional awareness and regulation, event-focused imaginal exposure, cognitive restructuring, resource activation, and adaptive coping strategies. A central component is the guided emotional processing of distressing life events and emotionally salient moments associated with the stressor. The intervention aims to reduce maladaptive avoidance and preoccupation, facilitate emotional processing, and support adaptation to changed life circumstances.

This randomised waitlist-controlled trial evaluates the efficacy of STEP in adults diagnosed with ICD-11 adjustment disorder. The primary hypothesis is that participants receiving STEP will demonstrate greater reductions in adjustment disorder symptoms than participants assigned to the waitlist condition. Secondary objectives include examining changes in psychological distress, experiential avoidance, and subjective well-being, as well as evaluating treatment feasibility and acceptability.

The study is expected to contribute to the development of targeted, evidence-based psychotherapeutic interventions for adjustment disorder.

Typ studie

Intervenční

Zápis (Odhadovaný)

70

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

  • Jméno: Rahel Bachem, Prof. Dr.
  • Telefonní číslo: +41 58 257 35 26
  • E-mail: rahel.bachem@ost.ch

Studijní místa

    • Canton of St. Gallen
      • Sankt Gallen, Canton of St. Gallen, Švýcarsko, 9001
        • Competence Center for Mental Health; Eastern Switzerland University of Applied Sciences
        • Kontakt:

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let a starší (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  • Age ≥ 18 years
  • Diagnosis of ICD-11 Adjustment Disorder confirmed via structured clinical interview using the IADQ diagnostic algorithm
  • Presence of a clearly identifiable psychosocial stressor 2 weeks to 2 years before participation
  • Sufficient German language proficiency to participate in psychotherapy and complete study assessments
  • Capacity to provide written informed consent

Exclusion Criteria:

  • Current PTSD or CPTSD meeting ICD-11 diagnostic criteria following a Criterion A traumatic event
  • Current prolonged grief disorder meeting ICD-11 diagnostic criteria
  • Lifetime history of bipolar disorder or psychotic disorder, including schizophrenia spectrum disorders
  • Severe depressive or anxiety symptoms clearly predating the identified stressor and judged to better account for the current clinical presentation
  • Another severe mental disorder that would interfere with participation in psychotherapy or better explain the presenting symptoms
  • Acute suicidality requiring immediate crisis intervention
  • Ongoing psychotherapy

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Žádné (otevřený štítek)

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: STEP Intervention Group

Participants assigned to the intervention group receive 12 weekly sessions of the STEP psychotherapy intervention after completion of the baseline assessment.

STEP is a brief, manualized, 12-session CBT-based psychotherapy specifically developed for ICD-11 Adjustment Disorder (AjD). It follows a staged, event-focused approach targeting the core symptom clusters of preoccupation and failure to adapt. Treatment components include psychoeducation and individualized case conceptualization, emotional awareness and regulation skills, stressor-focused imaginal exposure and emotional processing, cognitive and emotional reprocessing of stressor-related meanings, strengthening of personal resources and adaptive coping strategies, and relapse prevention.

Jiný: Waitlist Control Group

Participants assigned to the waitlist control group do not receive the STEP intervention during the 12-week waiting period. After completion of the waiting period, participants receive the STEP intervention.

STEP is a brief, manualized, 12-session CBT-based psychotherapy specifically developed for ICD-11 Adjustment Disorder (AjD). It follows a staged, event-focused approach targeting the core symptom clusters of preoccupation and failure to adapt. Treatment components include psychoeducation and individualized case conceptualization, emotional awareness and regulation skills, stressor-focused imaginal exposure and emotional processing, cognitive and emotional reprocessing of stressor-related meanings, strengthening of personal resources and adaptive coping strategies, and relapse prevention.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Adjustment Disorder Symptom Severity at Post-Treatment
Časové okno: Week 12-14 after baseline (T1; post-treatment in the immediate intervention group and post-waiting period in the control group)

Adjustment disorder symptom severity is assessed using the International Adjustment Disorder Questionnaire (IADQ). The primary outcome is the sum of six symptom items (Items 1-6), covering preoccupation with the stressor and failure to adapt. Each item is rated from 0 to 4, resulting in a total score ranging from 0 to 24, with higher scores indicating greater symptom severity. Scores at T1 will be compared between groups, adjusting for baseline scores.

Week 12-14 after baseline (T1; post-treatment in the immediate intervention group and post-waiting period in the control group)
Depressive Symptom Severity
Časové okno: Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Assessed using the International Depression Questionnaire (IDQ), measuring depressive symptoms according to ICD-11.

Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Anxiety Symptom Severity
Časové okno: Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Assessed using the International Anxiety Questionnaire (IAQ), measuring symptoms of generalized anxiety according to ICD-11.

Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
Perceived Stress
Časové okno: Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Assessed using the 10-item Perceived Stress Scale (PSS-10), measuring the perceived level of stress.

Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
Subjective Well-Being
Časové okno: Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Assessed using the World Health Organization-Five Well-Being Index (WHO-5), measuring subjective psychological well-being.

Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
Experiential Avoidance
Časové okno: Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Assessed using the Brief Experiential Avoidance Questionnaire (BEAQ), measuring the tendency to avoid unwanted internal experiences.

Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
Adjustment Disorder Diagnostic Status
Časové okno: Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Assessed through a structured clinical interview evaluating the presence or absence of ICD-11 adjustment disorder and diagnostic remission.

Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).
Treatment Credibility and Expectancy
Časové okno: Immediately after STEP Session 1

Assessed using the Credibility/Expectancy Questionnaire (CEQ), measuring treatment credibility and expected improvement.

Immediately after STEP Session 1
Treatment Acceptability and Feasibility
Časové okno: Immediately after completion of the 12-session STEP treatment

Assessed using the Treatment Feedback and Adherence questionnaire (TFA), evaluating participants' experiences with STEP.

Immediately after completion of the 12-session STEP treatment
Event-Focused Repetitive Thoughts
Časové okno: Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Assessed using the Event-focused Repetitive Thoughts Questionnaire (ERTQ), measuring repetitive thoughts related to stressful life events.

Baseline (T0), Week 12-14 (T1), and 3 months after treatment completion (T2).

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

1. ledna 2027

Primární dokončení (Odhadovaný)

1. března 2029

Dokončení studie (Odhadovaný)

1. května 2029

Termíny zápisu do studia

První předloženo

14. listopadu 2026

První předloženo, které splnilo kritéria kontroly kvality

14. listopadu 2026

První zveřejněno (Aktuální)

19. listopadu 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

19. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

14. listopadu 2026

Naposledy ověřeno

1. listopadu 2026

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • STEP_PILOTSTUDY
  • PT0041_222855 (Jiné číslo grantu/financování: Swiss National Science Foundation - SNSF)

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

ANO

Popis plánu IPD

A fully anonymized individual participant dataset will be made available in a publicly accessible scientific repository (e.g., OSF) following publication of the primary study results. All direct identifiers will be removed, and indirect identifiers will be minimized to prevent re-identification. No identifiable or coded participant data will be shared.

Časový rámec sdílení IPD

The anonymized individual participant dataset will become publicly available following publication of the primary study results. The dataset will remain accessible for as long as it is maintained in the selected public scientific data repository.

Kritéria přístupu pro sdílení IPD

The fully anonymized dataset will be publicly accessible to researchers and other interested users through an open scientific data repository, such as the Open Science Framework (OSF), without an individual access request. The shared dataset will contain numerical questionnaire data and broadly categorized demographic information. Free-text descriptions, exact age, geographical information, direct identifiers, and coded participant data will not be made publicly available. A data dictionary will accompany the dataset.

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit